Paget’s Disease
Paget’s Disease ( 45 Questions)
The nurse is monitoring a client receiving bisphosphonate therapy for Paget's disease. Which laboratory parameter should the nurse prioritize monitoring during treatment?
Liver function tests (LFTs): Bisphosphonates generally do not have a significant impact on liver function. Monitoring LFTs is not a primary concern during bisphosphonate therapy.
Monitoring serum calcium levels is important during bisphosphonate therapy for Paget's disease. Bisphosphonates can affect calcium metabolism, and monitoring calcium levels helps ensure appropriate dosing and prevent complications such as hypocalcemia or hypercalcemia.
Blood glucose levels: Bisphosphonate therapy is not known to affect blood glucose levels. Monitoring blood glucose is not directly related to Paget's disease treatment.
Complete blood count (CBC): Bisphosphonate therapy does not typically have a major effect on blood cell counts. Monitoring a CBC is not a primary concern during bisphosphonate treatment for Paget's disease.
Monitoring serum calcium levels is important during bisphosphonate therapy for Paget's disease. Bisphosphonates can affect calcium metabolism, and monitoring calcium levels helps ensure appropriate dosing and prevent complications such as hypocalcemia or hypercalcemia.
a. Liver function tests (LFTs): Bisphosphonates generally do not have a significant impact on liver function. Monitoring LFTs is not a primary concern during bisphosphonate therapy.
c. Blood glucose levels: Bisphosphonate therapy is not known to affect blood glucose levels. Monitoring blood glucose is not directly related to Paget's disease treatment.
d. Complete blood count (CBC): Bisphosphonate therapy does not typically have a major effect on blood cell counts. Monitoring a CBC is not a primary concern during bisphosphonate treatment for Paget's disease.